Abivax (ABVX FP) spokesperson denies AstraZeneca's (AZN LN) takeover rumours
Newsquawk Staff ·
Abivax (ABVX FP) spokesperson denies AstraZeneca's (AZN LN) takeover rumours.
What it means
The denial from Abivax regarding takeover rumors by AstraZeneca could temper speculation and volatility in both companies' stock prices. Since M&A rumors often drive market movement, this clarification reduces uncertainty but could also prompt traders to reassess valuation metrics and forecasts for possible future deals in the sector.
- Stellantis (STLAM IM) earnings call summary: Co. firmly believes will beat initial goal of EUR 2.4bln cost savings in 2027
- Daily US Conference Calendar - 28th October 2026: JNJ, BA, CAT
- Eli Lilly’s (LLY) retatrutide delivered greater A1C reduction and more than double the weight loss of Novo Nordisk’s (NOVOB DC) Ozempic at its highest approved dose in head-to-head trial
- Biogen Inc. (BIIB) Q3 2026 (USD): Adj. EPS 2.62 (exp. 1.98), Revenue 2.8bln (exp. 2.63bln). Raises lower end of FY26 diluted EPS guidance to USD 12.20-13.00 (exp. 12.23, prev. 12.00-13.00)
- Santander (SAN SM) Q3 (EUR) net 3.43bln (exp. 3.41bln), rev. 16.0bln (prev. 15.3bln Y/Y)
Related headlines
- Mercedes-Benz Group (MBG GY) CEO says the Co. is preparing a broader strategy update covering 2030 and beyond, with China remaining a core pillar of its long-term plans3 hours ago
- Intesa Sanpaolo (ISP IM) receives ECB approval for its Monte dei Paschi (BMPS IM) bid 19 hours ago
- Novo Nordisk (NOVOB DC) to present new liver data across Wegovy 2.4mg and investigational efruxifermin at The Liver Meeting 20261 hour ago
- Epiroc (EPIA SS) Q3 2026 (SEK): Revenue 16.8bln (exp. 17.4bln), Orders 17.5bln (exp. 17.8bln), Adj. EBIT 3.43bln (exp. 3.49bln)4 hours ago
- Orion (ORNBV FH) Q3 2026 (EUR): Sales 542.2mln (exp. 546.7mln). Raises its FY26 Net sales guidance to 2.07-2.14bln (prev. guided 2-2.1bln)4 hours ago
- EUROPEAN MOVERS: Standard Chartered (STAN LN) +4.5%, Deutsche Bank (DBK GY) +3.3%, BASF (BAS GY) +0.9%, Danone (BN FP) +0.9%, BNP Paribas (BNP FP) U/C, Santander (SAN SM) -3.2%, GSK (GSK LN) -4.8%6 hours ago
- EUROPEAN OPEN: SKHY surges after Q3 profits; EQNR NO lifts FY production view; UBSG SW Q3 net income miss; DBK GY posts third straight record profit; MBG GY Q3 revenue & earnings fall; ULVR LN raises FY volume growth view; GSK LN Q3 profit & revenue beat6 hours ago
- Newsquawk Daily European Equity Opening News - 28th October 20267 hours ago
- Saint Gobain (SGO FP) Q3 2026 (EUR): Sales 11.6bln (exp. 11.6bln)21 hours ago
- Canada's Competition Bureau says proposed arrangements between Air Canada and United Airlines (UAL) would lead to higher prices, with the Transport Minister set to review the findings of its investigation25 min ago
- JPMorgan Chase (JPM) reportedly faces an additional GBP 100-150mln tax bill following the UK government's decision to double the corporation tax surcharge on banks, potentially jeopardising plans for its new London headquarters, Sky News reports27 min ago
- US EQUITY OPEN: Indices rangebound ahead of FOMC and major earnings42 min ago
- Al-Mayadeen correspondent in Iran says Iranian officials believe that Trump wants to bring the nuclear issue into the negotiations, which Iran rejects1 hour ago
- Verisk (VRSK) integrates insurance intelligence with Amazon (AMZN) and Microsoft (MSFT) AI platforms1 hour ago
- Senior US Treasury trade official Eric Ettorre will leave to join Netflix (NFLX), reports Axios1 hour ago